Obalon Announces First Patient Treatments at its First Company-Owned Center for Weight Loss

SAN DIEGO, Oct. 22, 2019 (GLOBE NEWSWIRE) — Obalon Therapeutics, Inc. (NASDAQ:OBLN), a?weight loss solutions company with the first and only?FDA-approved swallowable, gas-filled intra-gastric balloon for non-surgical weight loss,?announces it has treated the first patients at its Company-owned weight loss treatment center, the Obalon Center for Weight Loss, in San Diego, California.